FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to predict the risk of locoregional recurrence in patients with lung cancer after pneumonectomy. Computed tomography of the chest organs is carried out 6 and 12 months after the operation. Using any program for viewing DICOM files with the function of determining the volume, the volume of the post-pneumonectomy cavity is estimated and compared with the volume of the cavity of the previous study. In cases where the volume of the cavity increases or remains the same, i.e. the ratio of the previous volume to the present volume is less than or equal to 1.0, the development of a locoregional relapse of lung cancer in a patient is predicted.
EFFECT: method provides assessment of the risk of locoregional recurrence in patients with lung cancer after pneumonectomy by determining the volume of the post-pneumonectomy cavity.
1 cl, 6 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF RECURRENT DISEASE OF SQUAMOUS CELL LUNG CANCER OF STAGE IIB-IIIA IN PATIENTS RECEIVING ADJUVANT POLYCHEMOTHERAPY AFTER RADICAL SURGERY | 2023 |
|
RU2815575C1 |
METHOD FOR PREDICTION OF ONSET OF HEMATOGENOUS METASTASES ACCOMPANYING SQUAMOUS CELL LUNG CANCER | 2012 |
|
RU2489718C1 |
METHOD OF TREATING RECURRENT NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2558473C1 |
METHOD FOR COMBINED TREATMENT OF STAGE II-III NON-SMALL-CELL LUNG CANCER | 2017 |
|
RU2636869C1 |
METHOD OF COMBINED TREATMENT OF NON-SMALL CELL CANCER OF LUNG OF III STAGE | 2007 |
|
RU2340336C1 |
METHOD OF COMBINATION TREATMENT OF NON-SMALL CELL LUNG CANCER STAGE 1B-111 WITH CUSTOMIZATION OF ADJUVANT CHEMOTHERAPY | 2015 |
|
RU2593342C1 |
METHOD OF MONITORING EFFICIENCY OF ANTICANCER THERAPY OF NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2611340C2 |
METHOD FOR THE SYNCHRONOUS LYMPHATIC METASTASIS PREDICTION IN THE PATIENTS WITH NON-SMALL CELL LUNG CANCER FOLLOWING THE NEOADJUVANT CHEMOTHERAPY | 2020 |
|
RU2740850C1 |
METHOD FOR PERSONALIZED COMBINED TREATMENT OF PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER STAGE II-III | 2022 |
|
RU2784958C1 |
METHOD OF COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER OF II AND III STAGE | 2011 |
|
RU2455986C1 |
Authors
Dates
2021-05-06—Published
2019-06-18—Filed